Spondylitis

Common Name(s)

Spondylitis

Description for this condition is not yet available.
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Spondylitis" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Spondylitis" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Spondylitis" returned 1248 free, full-text research articles on human participants. First 3 results:

Xinfeng capsule improves pulmonary function in ankylosing spondylitis patients via NF-ΚB-iNOS-NO signaling pathway.
 

Author(s): Jian Liu, Yajun Qi, Li Zheng, Yunxiang Cao, Lei Wan, Wenfang Ye, Li Fang

Journal: J Tradit Chin Med. 2014 Dec;34(6):657-65.

 

To study changes in the nuclear factor-κB p65 (NF-κB p65)-inducible nitric oxide synthase (iNOS)-nitric oxide (NO) signaling pathway and the effects of Xinfeng capsules (XFC) in patients with ankylosing spondylitis (AS).

Last Updated: 26 Jan 2015

Go To URL
The VEGF and BMP-2 levels in patients with ankylosing spondylitis and the relationship to treatment with tumour necrosis factor alpha inhibitors.
 

Author(s): Marian Tošovský, Petr Bradna, Ctirad Andrýs, Kateřina Andrýsová, Eva Cermáková, Tomáš Soukup

Journal: Acta Medica (Hradec Kralove). 2014 ;57(2):56-61.

 

Ankylosing spondylitis (AS) is an inflammatory rheumatic disease characterized by the development of osteoproductive changes in the spine which could possibly result in ankylosis. Treatment with tumour necrosis factor alpha (TNFα) inhibitors has proved to be an important step forward ...

Last Updated: 26 Sep 2014

Go To URL
Ankylosing spondylitis is associated with the anthrax toxin receptor 2 gene (ANTXR2).
 

Author(s): T Karaderi, S M Keidel, J J Pointon, L H Appleton, M A Brown, D M Evans, B P Wordsworth

Journal: Ann. Rheum. Dis.. 2014 Nov;73(11):2054-8.

 

ANTXR2 variants have been associated with ankylosing spondylitis (AS) in two previous genome-wide association studies (GWAS) (p∼9×10(-8)). However, a genome-wide significant association (p<5×10(-8)) was not observed. We conducted a more comprehensive analysis of ANTXR2 in an independent ...

Last Updated: 7 Oct 2014

Go To URL

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Spondylitis" returned 89 free, full-text review articles on human participants. First 3 results:

Comparative efficacy and safety of biosimilar infliximab and other biological treatments in ankylosing spondylitis: systematic literature review and meta-analysis.
 

Author(s): Petra Baji, Márta Péntek, Sándor Szántó, Pál Géher, László Gulácsi, Orsolya Balogh, Valentin Brodszky

Journal: Eur J Health Econ. 2014 May;15 Suppl 1():S45-52.

 

To compare the efficacy and safety of infliximab-biosimilar with other biological drugs for the treatment of active ankylosing spondylitis (AS).

Last Updated: 6 Jun 2014

Go To URL
Adipokines, biomarkers of endothelial activation, and metabolic syndrome in patients with ankylosing spondylitis.
 

Author(s): Fernanda Genre, Raquel López-Mejías, José A Miranda-Filloy, Begoña Ubilla, Beatriz Carnero-López, Ricardo Blanco, Trinitario Pina, Carlos González-Juanatey, Javier Llorca, Miguel A González-Gay

Journal: Biomed Res Int. 2014 ;2014():860651.

 

Ankylosing spondylitis (AS) is a chronic inflammatory rheumatic disease associated with accelerated atherosclerosis and increased risk of cardiovascular (CV) disease. AS patients also display a high prevalence of features clustered under the name of metabolic syndrome (MeS). Anti-TNF- ...

Last Updated: 23 Apr 2014

Go To URL
Measurement and treatment of radiographic progression in ankylosing spondylitis: lessons learned from observational studies and clinical trials.
 

Author(s): Grant H Louie, Michael M Ward

Journal: Curr Opin Rheumatol. 2014 Mar;26(2):145-50.

 

One of the major goals of treatment of ankylosing spondylitis is to prevent or slow the development of spinal new bone formation. Recent observational studies are compared with the results from clinical trials for the effects of tumor necrosis factor-alpha inhibitors (TNFi) and NSAIDs ...

Last Updated: 4 Feb 2014

Go To URL
 
 
Top

Symptoms, Diagnosis, and Treatment

There are currently no related results available in GeneReviews.

There are currently no related results available in Genetic Testing Registry.

 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

Dose-Ranging Study Of Tofacitinib In Adults With Active Ankylosing Spondylitis
 

Status: Recruiting

Condition Summary: Ankylosing Spondylitis

 

Last Updated: 4 Mar 2015

Go to URL
Progression of Spinal Fusion in Ankylosing Spondylitis
 

Status: Recruiting

Condition Summary: Spondylitis, Ankylosing

 

Last Updated: 11 Nov 2014

Go to URL